Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanism
Authors:
- Eric W. DicksonEDEric W. Dickson
- Christopher P. HogrefeCHChristopher P. Hogrefe
- Paula S. LudwigPLPaula S. Ludwig
- Laynez W. AckermannLALaynez W. Ackermann
- Lynn L. StollLSLynn L. Stoll
- Gerene M. DenningGDGerene M. Denning
- 1 January 2008
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 294 (1) , H402-H408
Abstract
Exercise increases serum opioid levels and improves cardiovascular health. Here we tested the hypothesis that opioids contribute to the acute cardioprotective effects of exercise using a rat model of exercise-induced cardioprotection. For the standard protocol, rats were randomized to 4 days of treadmill training and 1 day of vigorous exercise ( day 5), or to a sham exercise control group. On day 6, animals were killed, and global myocardial ischemic tolerance was assessed on a modified Langendorff apparatus. Twenty minutes of ischemia followed by 3 h of reperfusion resulted in a mean infarct size of 42 ± 4% in hearts from sham exercise controls and 21 ± 3% ( P < 0.001) in the exercised group. The cardioprotective effects of exercise were gone by 5 days after the final exercise period. To determine the role of opioid receptors in exercise-induced cardioprotection, rats were exercised according to the standard protocol; however, just before exercise on days 4 and 5, rats were injected subcutaneously with 10 mg/kg of the opioid receptor antagonist naltrexone. Similar injections were performed in the sham exercise control group. Naltrexone had no significant effect on baseline myocardial ischemic tolerance in controls (infarct size 43 ± 4%). In contrast, naltrexone treatment completely blocked the cardioprotective effect of exercise (infarct size 40 ± 5%). Exercise was also associated with an early increase in myocardial mRNA levels for several opioid system genes and with sustained changes in a number of genes that regulate inflammation and apoptosis. These findings demonstrate that the acute cardioprotective effects of exercise are mediated, at least in part, through opioid receptor-dependent mechanisms that may include changes in gene expression.Keywords
This publication has 50 references indexed in Scilit:
- Met5-enkephalin-Arg6-Phe7(MEAP): A Cardioprotective Hormonal OpioidAcademic Emergency Medicine, 2006
- TNF-α-mediated cardiomyocyte apoptosis involves caspase-12 and calpainBiochemical and Biophysical Research Communications, 2006
- Potential candidates for ischemic preconditioning-associated vascular growth pathways revealed by antibody arrayAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Role of apoptosis-inducing factor in myocardial cell death by ischemia–reperfusionBiochemical and Biophysical Research Communications, 2003
- Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problemsJournal of Molecular Endocrinology, 2002
- Delta Opiates Increase Ischemic Tolerance in Isolated Rabbit JejunumAcademic Emergency Medicine, 2002
- Delta Opiates Increase Ischemic Tolerance in Isolated Rabbit JejunumAcademic Emergency Medicine, 2002
- Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assaysJournal of Molecular Endocrinology, 2000
- The variable morphological coexistence of apoptosis and necrosis in human myocardial infarctionCoronary Artery Disease, 1998
- The Incidence of Primary Cardiac Arrest during Vigorous ExerciseNew England Journal of Medicine, 1984